A key initiator of ECM degradation during the course of IDD is chronic inflammation, which results from increased secretion of pro-inflammatory cytokines (i.e., interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-6). This evidence concerns the gene IL1B and intervertebral disk degenerative disorder.